“The technology platform developed by Gain is revolutionizing the management of complex medical claims through the seamless integration of advanced AI solutions. We are excited and honored to receive this recognition by the SIIA,” said Gain Vice President of Operations and Technology Jonathan Razza.

ATLANTA (PRWEB)
June 22, 2023

Gain, a comprehensive medical lien servicing and legal funding company with an artificial intelligence-powered platform, was named the best healthcare technology solution of 2023 as part of the annual SIIA CODiE Awards. The prestigious CODiE Awards recognize the companies producing the most innovative business and education technology products across the country and around the world.

“The technology platform developed by Gain is revolutionizing the management of complex medical claims through the seamless integration of advanced AI solutions. Our platform empowers attorneys and healthcare providers to collaborate more effectively, resulting in higher reimbursements and the ability to help more patients in need. We are excited and honored to receive this recognition by the Software & Information Industry Association in their annual CODiE Awards program, which further validates our commitment to innovation to help injured patients,” said Gain Vice President of Operations and Technology Jonathan Razza.

Gain’s AI platform assists attorneys and healthcare providers in accurately understanding case values and informing them of the available funds for reimbursements to all parties, leading to more effective treatment and better financial outcomes.

“Our AI technology equips attorneys and healthcare providers with predictive analytics capabilities, providing valuable business intelligence. The AI-enhanced reports shed light on payor sources, case characteristics, jurisdictions, third-party liability carriers, financial outcomes and other vital decision-making factors. It is changing the way injured plaintiffs fight for themselves and get access to the medical treatment they deserve. We are thrilled to serve at this critical junction, and to have our technology recognized by a prestigious award program like the CODiE is truly an honor,” said Gain Founder and CEO Reid Zeising.

In 2023 alone, Gain has been recognized in the Inc. Regionals Southeast list of the fastest-growing private companies in America, by the Atlanta Business Chronicle as a 2023 Pacesetter and most recently by the Technology Association of Georgia as a Top 40 Innovative Technology Companies in Georgia.

“The 2023 Business Technology and Education Technology CODiE Award winners exemplify the outstanding products, services and overall innovation that enables learners of all types to connect with educators and educational materials,” said SIIA President Chris Mohr. “We are so proud to recognize this year’s honorees – the best of the best – that provide solutions to many of the critical challenges facing learners today – from access and equity, to personalized and tailored learning and beyond. Congratulations to all of this year’s CODiE Award winners!”

The Software & Information Industry Association, the principal trade association for the software and digital content industries, announced the full slate of CODiE winners during a virtual business technology award celebration and showcase in the Metaverse on June 21, 2023.

A SIIA CODiE Award win is a prestigious honor, following rigorous reviews by expert judges including educators and administrators whose evaluations determined the finalists. SIIA members then vote on the finalist products, and the scores from both rounds are tabulated to select the winners.

Details about the winning products can be found at https://siia.net/codie/celebrate-finalists/.

About Gain

Gain is the fastest growing medical lien servicing and legal funding company in the United States. Gain’s innovative artificial intelligence-enabled servicing platform and its collective services and solutions come together to meaningful serve the personal injury ecosystem and create better outcomes. Gain is the critical hub connecting medical providers, lawyers and personal injury plaintiffs. Gain’s industry-leading platform serves as the source of truth, providing both needed transparency and efficiency for all of those supporting personal injury cases and plaintiffs. Gain is committed to leveling the insurance playing field for those injured through no fault of their own. To learn more, go to gainservicing.com.

About the CODiE Awards

The SIIA CODiE Awards is the only peer-reviewed program to showcase business and education technology’s finest products and services. Since 1986, thousands of products, services and solutions have been recognized for achieving excellence. For more information, visit siia.net/CODiE.

Share article on social media or email:

Pureboost Launches Apple Cider Vinegar

“Typically, apple cider vinegar products can be deceiving, as they are often made with sugar, which is counterproductive to blood glucose management. Our product provides all the great benefits of apple cider vinegar while using clean ingredients and natural sweeteners to make it taste amazing.”

SAN DIEGO (PRWEB)
June 22, 2023

Pureboost, Amazon’s number one best-selling antioxidant clean energy drink, launches its newest product – Apple Cider Vinegar. In the convenience of a portable pack, Pureboost Apple Cider Vinegar is part of their Superfoods Clean Energy segment, and, as with all other products, is completely free of sugar and sucralose. Promising “All of the Benefits (of Apple Cider Vinegar), with None Of the Bite,” this new launch comes right after Pureboost has closed its latest round, where the company raised over $2.8 million via WeFunder.

“Typically, apple cider vinegar products can be deceiving, as they are often made with sugar, which is counterproductive to blood glucose management,” says Pureboost CEO Jay Mercer. “What’s exciting about our product is that it provides all the great benefits of apple cider vinegar while using clean ingredients and natural sweeteners to make it taste amazing. We combined this with B12, vitamins, minerals and electrolytes to maximize the benefits and make you feel great. We’re thrilled to be expanding our line of products, and energized by the support we’ve received in our latest community investment raise on WeFunder.”

Pureboost recently wrapped their raise of over $2.8 million, with over 700 investors from their loyal fan base as well as first time users, showcasing true brand affinity. The company has seen success with over $8.5 million in revenue in 2022, thus taking on the fast-growing $400 billion energy drink market. They are set to hit $100 million in revenue by 2026.

Each packet of Pureboost Apple Cider Vinegar has 1000 mg of apple cider vinegar formulated with B12, natural green tea caffeine and 25 key vitamins to support metabolism, digestion and gut health, while also offering a crash-free energy boost. It is available at Pureboost.com and is priced at $33.99.

Pureboost is the #1 best-selling healthy category leader on Amazon, with double-digit annual growth since launch and more than 25,000 positive reviews. Pureboost also has their Original, Superfoods and Immune product lines available on Costco.com and in 2,500 stores around America including Walgreens, Walmart, and Meijer.

About Pureboost: Founded by a team of four parents and active lifestyle individuals, Pureboost is a line of clean energy drink mixes formulated with clean ingredients. It’s sugar-free, sucralose-free, non-gmo and made with natural flavors and colors. It’s made in the USA from globally-sourced ingredients with all of the good stuff and none of the bad, so consumers can have all of the boost with none of the guilt.

Share article on social media or email:

A female patient at Laser & Cosmetic Surgery and Specialists after receiving Restylane Eyelight treatment.

NEWBURGH, N.Y. (PRWEB)
June 22, 2023

The battle against aging and tired-looking eyes has a new ally with Laser & Cosmetic Surgery Specialists introducing the latest addition to their range of top-tier aesthetic services: Restylane® Eyelight™. This groundbreaking treatment targets under-eye shadows, a common concern for many, with an innovative hyaluronic acid-based filler designed to refresh and rejuvenate the eye area.

Steering the helm of this advanced offering is the highly respected facial plastic surgeon Dr. Ran Rubinstein. With over 20 years of experience and a commitment to staying at the forefront of industry advancements, Dr. Rubinstein is now bringing the benefits of Restylane® Eyelight™ to his valued patients.

In an industry where staying current is crucial, Dr. Rubinstein not only offers the most innovative treatments but is also an active contributor to the advancement of aesthetic medicine. He has been selected as a certified national trainer for Restylane® Eyelight™ by Galderma, the global dermatology company behind the product. This significant recognition endorses his vast experience and expertise, and it’s with great honor that he will be teaching other professionals to perform this transformative procedure.

With the introduction of Restylane® Eyelight™, Laser & Cosmetic Surgery Specialists continue their commitment to provide their patients with the highest standards of care. This innovative treatment signifies a remarkable leap forward in the fight against tired-looking eyes, and the practice is thrilled to guide its patients through their aesthetic journey, helping them achieve their desired outcomes.

What is Restylane® Eyelight™?

Restylane® Eyelight™ is a breakthrough in aesthetic medicine, providing a non-surgical, FDA-approved solution for individuals troubled by the appearance of under-eye shadows. This condition, often associated with fatigue and aging, is now effectively treatable with an innovative approach courtesy of Galderma, a leading global dermatology company.

Restylane® Eyelight™ utilizes a hyaluronic acid-based filler, a substance naturally found in the human body and known for its hydration and volume-enhancing properties. The treatment targets the under-eye area, diminishing the appearance of shadows and bringing patients a fresh, revitalized look.

The science behind Restylane® Eyelight™ is based on Galderma’s patented Non-Animal Stabilized Hyaluronic Acid (NASHA) technology. This cross-linking technology creates a firmer gel-like substance that is ideal for filling under-eye hollows and softening the appearance of shadows. The safety and efficacy of NASHA gel technology have been extensively evaluated, earning the trust of healthcare practitioners worldwide for over 25 years.

The FDA approval of Restylane® Eyelight™ signifies a significant step forward in aesthetic medicine, emphasizing its safety and efficacy for patient use. The procedure promises to usher in a new era in under-eye treatment options, providing a compelling solution for those desiring a more youthful and alert appearance without undergoing invasive surgery.

The application of Restylane® Eyelight™ is a meticulous process, requiring a provider with thorough knowledge of anatomy and experience. That’s why choosing a board-certified facial plastic surgeon like Dr. Ran Rubinstein ensures the best possible results.

Dr. Rubinstein Selected as a Restylane® Eyelight™ Trainer by Galderma

As a testament to his vast experience and expertise in the field of aesthetic medicine, Dr. Ran Rubinstein has been personally selected by Galderma to become a certified trainer for the Restylane® Eyelight™ procedure. This role highlights his extensive skills and competence in providing aesthetic treatments, especially the newly introduced under-eye shadow correction.

As a trainer, Dr. Rubinstein is responsible for teaching and guiding other professionals on how to perform this cutting-edge procedure, sharing his wealth of knowledge and expertise to ensure that the highest standards of patient care are met across the board. This position is not just an endorsement of Dr. Rubinstein’s skills but a reflection of his dedication to the advancement of the industry as a whole.

About Dr. Ran Rubinstein

With a passion for helping his patients achieve their aesthetic goals, Dr. Ran Rubinstein is a board-certified facial plastic surgeon who has dedicated over 20 years to the field of cosmetic and reconstructive surgery. He leads the Laser & Cosmetic Surgery Specialists team with a commitment to excellence, offering his patients access to the most advanced and effective treatments available.

Renowned for his expertise in facial procedures, Dr. Rubinstein often mentors other practitioners in the industry, sharing his knowledge and innovative techniques. His selection as a certified national trainer for Restylane®️️️ Eyelight™ reaffirms his esteemed reputation and ongoing commitment to leading-edge patient care.

Dr. Rubinstein’s dedication extends beyond his practice; he was a Clinical Professor at the New York-Presbyterian Hospital for 15 years and continues to be involved in physician education. His continuous engagement in the medical community underscores his devotion to ensuring patients receive the highest level of care and have access to the latest advancements in the field.

The opportunity to consult with Dr. Rubinstein about the Restylane® Eyelight™ treatment offers patients the unique advantage of discussing their aesthetic goals with a recognized expert in the field and a trainer for the procedure. His dedication to patient satisfaction and consistent delivery of outstanding results make Dr. Rubinstein an ideal choice for those considering Restylane® Eyelight™.

If under-eye shadows are causing you concern, consider booking a consultation with Dr. Rubinstein to discuss the benefits of Restylane® Eyelight™. For further information or to schedule an appointment, please visit the Laser & Cosmetic Surgery Specialists website or contact the practice directly at 845-863-1772.

Share article on social media or email:

The World Health Organization (WHO) has certified Belize for achieving malaria elimination, a significant milestone more than 70 years in the making.

Margaret Reilly McDonnell, Executive Director of United to Beat Malaria: “Today, we celebrate the investment and perseverance of the Belize government, vector control personnel, frontline health workers, and local communities who have diligently worked to wipe out malaria…”

WASHINGTON (PRWEB)
June 21, 2023

The World Health Organization (WHO) has certified Belize for achieving malaria elimination, a significant milestone more than 70 years in the making. Belize becomes the second Central American country, after El Salvador, and 42nd country (plus one territory) worldwide to receive malaria-free certification.

“Belize is the latest success story in the decades-long global fight to end malaria,” said United Nations Foundation President and CEO Elizabeth Cousens. “This milestone is a testament to the power of sustained government commitment and strategic partnerships across borders, sectors, and communities. Together, we can eradicate this deadly disease and deliver on the Sustainable Development Goals’ promise of good health and well-being for all.”

A century ago, it was estimated that malaria caused approximately 10% of all deaths in Belize. Frequent population movement to and from malaria-endemic areas – mainly Mexico, Guatemala, and Honduras – has complicated efforts to control the disease.

Nevertheless, Belize made significant progress in the latter 20th century through the strategic use of indoor residual spraying and a national network of community health workers and volunteers, driving down transmission to under 2,000 cases annually by 2000 and under 100 cases by 2011.

This century, the vast majority of cases have occurred in remote rural areas among indigenous and migrant populations. Belize’s government prioritized these high-risk groups, effectively coordinating across sectors and borders to maintain malaria surveillance, provide prompt access to diagnosis and treatment, and respond to every single malaria case. The country reported its last indigenous malaria case in December 2018.

“Today, we celebrate the investment and perseverance of the Belize government, vector control personnel, frontline health workers, and local communities who have diligently worked to wipe out malaria – a disease that was once widespread throughout the country,” said Margaret Reilly McDonnell, Executive Director of the United to Beat Malaria campaign. “Belize’s success should inspire us all to act with renewed urgency to achieve a malaria-free future for the Americas and the world.”

Regional and global partners have played an important role in helping Belize reach and sustain zero cases. The Pan American Health Organization (PAHO), a longtime technical partner, has helped the Belize government build its capacity for prompt malaria diagnosis, treatment, and surveillance. The Inter-American Development Bank; the Bill & Melinda Gates Foundation; the Carlos Slim Foundation; the U.S. Agency for International Development; and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria are among the partners who’ve made catalytic investments in regional elimination efforts that have strengthened Belize’s fight to end malaria.

Over the past seven years, United to Beat Malaria has been proud to support PAHO and other UN partners in the Americas region. This work has helped ensure the most at-risk populations and communities – such as pregnant women, children under five, migrant populations, and indigenous communities with limited access to healthcare – have access to bed nets, rapid diagnostic tests, anti-malarial treatments, and other vital malaria tools.

Learn more about Belize’s journey to malaria elimination by visiting ‘Malaria on the Frontlines: Belize,’ United to Beat Malaria’s multimedia feature story.

###

About United to Beat Malaria

The United to Beat Malaria campaign brings together key and diverse partners and supporters to take urgent action to end malaria and create a healthier, more equitable world. Since 2006, United to Beat Malaria has worked to equip and mobilize citizens across the U.S. and around the world to raise awareness, funds and voices. The campaign works with partners in endemic countries to channel life-saving resources to protect the most marginalized and vulnerable populations. By championing increased leadership, political will and resources from the U.S. and beyond, as well as more holistic, innovative tools and strategies, we can be the generation that ends malaria once and for all. Learn more at http://www.beatmalaria.org

About the UN Foundation

For 25 years, the UN Foundation has built novel innovations and partnerships to support the United Nations and help solve global problems at scale. As an independent charitable organization, the Foundation was created to work closely with the United Nations to address humanity’s greatest challenges and drive global progress. Learn more at http://www.unfoundation.org

Share article on social media or email:

Mount Sinai Health System expands digital tools including virtual urgent care, virtual primary care and symptoms checker

“Mount Sinai is committed to providing a seamless digital experience that encourages our patients to proactively engage with their care team, manage their health progress, and take advantage of ongoing support and resources,” said Kristin Myers, MPH, Executive Vice President at Mount Sinai.

NEW YORK (PRWEB)
June 21, 2023

Mount Sinai Health System patients will experience greater access to care, fast identification of symptoms, efficient online search and connection to specialists, and easy appointment scheduling thanks to newly launched Digital Experience tools accessible on their smartphones or computers.

These digital tools include Virtual Urgent Care to address non-emergencies such as the flu or mild COVID-19 infection, Virtual Primary Care to schedule doctor visits including annual wellness exams, and Check Symptoms & Get Care, an intelligent care navigation system that includes a short questionnaire for patients to self-identify their ailments and a personalized list of telehealth or in-person care options based on their results.

Mount Sinai is the first health system in New York City to use this digital self-triage system, developed by Mount Sinai’s Digital and Technology Partners department in partnership with Clearstep, an artificial intelligence chat health care assistant.

The Check Symptoms & Get Care platform uses natural language processing, a branch of artificial intelligence, to translate complex medical data into user-friendly content. This tool can currently identify and match more than 300 unique primary symptoms. The new suite of digital tools also includes Mount Sinai Virtual Assistant, which can assist patients with questions and manage appointments.

“Mount Sinai is committed to providing a seamless digital experience that encourages our patients to proactively engage with their care team, manage their health progress, and take advantage of ongoing support and resources,” said Kristin Myers, MPH, Executive Vice President and Chief Digital and Information Officer of the Mount Sinai Health System and Dean for Digital and Information Technology of the Icahn School of Medicine at Mount Sinai. “Our latest digital tools also leverage automation and integration throughout the Health System, streamlining processes and support services, so our priority and focus remains continuity of care and equitable access to services for our diverse community.”

The Digital Experience tools expand on existing capabilities of MyMountSinai, a mobile app developed in 2021, as an online gateway to Mount Sinai physicians and services. Through MyMountSinai, patients are able to access health records and lab results, schedule appointments, check in for appointments, conduct video visits, pay bills, and request prescription refills.

“We know access to high-quality services—including urgent, primary and specialty care—is imperative for healthy communities,” said Kelly Cassano, DO, Chief Executive Officer of the Mount Sinai Doctors Faculty Practice, Dean for Clinical Affairs at Icahn Mount Sinai, and Senior Vice President for Ambulatory Operations of the Mount Sinai Health System. “Through transformative innovation and expansion of our telehealth options, Mount Sinai continues to deliver world-leading care, especially when and where our patients most conveniently need it.”

Patients can log into either the MyMountSinai website or mobile app and navigate the main menu tab to select Check Symptoms & Get Care under the Find Care section. All of Mount Sinai’s Digital Experience tools can be accessed at Digital Patient Tools and Resources.

To learn more about how to use the Digital Experience tools, watch a video here.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Together, we have created a culture of excellence that places our healthcare system at the forefront of pediatric orthopedics.

TAMPA, Fla. (PRWEB)
June 21, 2023

Shriners Children’s has once again been ranked nationally for pediatric orthopedics in the “2023-2024 Best Children’s Hospitals” rankings published by U.S. News & World Report, the global authority in hospital rankings and consumer advice.

The “Best Children’s Hospitals” rankings, which highlight the top 50 centers in 10 pediatric specialties, are designed to help families of children with rare or life-threatening illnesses find the best medical care available.

The following Shriners Children’s locations ranked in pediatric orthopedics:

o #13 – Shriners Children’s St. Louis

· (together with St. Louis Children’s Hospital – Washington University)

o #20 – Shriners Children’s Northern California

· (together with UC Davis Children’s Hospital)

o #42 – Shriners Children’s Lexington

· (together with Kentucky Children’s Hospital)

o #42 – Shriners Children’s Portland

· (together with Doernbecher Children’s Hospital)

The hospitals were ranked in pediatric orthopedics for treatment of conditions such as scoliosis and spina bifida, and injuries such as complex fractures or other sports injuries. Success with complex fractures, surgical complications and infection prevention accounted for most of each hospital’s score.

“We are honored to be recognized as part of the 2023 U.S. News & World Report rankings,” said Frances A. Farley, M.D., chief medical officer of Shriners Children’s. “This significant accomplishment is a testament to the hard work, expertise and compassionate care provided by our entire staff. Together, we have created a culture of excellence that places our healthcare system at the forefront of pediatric orthopedics. We would like to thank all who participated in the process, and congratulate our ranked pediatric orthopedic programs, along with their affiliates.”

To create the pediatric rankings, U.S. News & World Report gathers key clinical data through a detailed survey that looks at measures such as patient safety, infection prevention and adequacy of nurse staffing. In addition, part of each hospital’s score is derived from surveys of thousands of pediatric specialists who are asked where they would send the sickest children in their specialty.

This year’s rankings will be published in the U.S. News & World Report’s “Best Hospitals Guidebook,” which is expected to be available in stores this fall.

About Shriners Children’s

Shriners Children’s is a leader in providing care for orthopedic conditions, burn injuries, spinal cord injuries and other spine disorders, rehabilitation, sports injuries and craniofacial conditions. We also offer specialized services, including orthotics and prosthetics, and motion analysis. We strive to provide the care and support our patients need to reach their goals and discover their full potential. In addition, our healthcare system conducts research to improve our patients’ quality of life and offers outstanding educational programs for medical professionals. All care and services are provided regardless of the families’ ability to pay or insurance status.

Shriners Children’s is a nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law. For more information, including the full range of care disciplines, please visit shrinerschildrens.org.

###

Contact:

Ashley Ozols-Thomas

Cell: 813-499-4273

aozols@shrinenet.org

Share article on social media or email:

“WeInfuse integration with Prochant Pulse reflects our commitment to empowering infusion providers through advanced technology. It’s about reshaping industry standards and revolutionizing RCM operations,” said Jon Love, VP of Pharmacy Services at Prochant.

CHARLOTTE, N.C. (PRWEB)
June 21, 2023

Prochant, the only AI-driven infusion pharmacy reimbursement service, announced today that WeInfuse, the premier technology platform for infusion therapy and medication delivery in the US, now integrates with Prochant Pulse. This integration with Prochant Pulse, an innovative proprietary RCM workflow & analytics platform, enables efficient and proactive reimbursement operations, revolutionizing the way pharmacies manage their revenue cycles.

Prochant Pulse, a state-of-the-art revenue cycle management (RCM) workflow & analytics platform, equips ambulatory infusion center (AIC), home infusion, specialty pharmacy, and other home-based care providers with streamlined monitoring and management of accounts receivable (AR) balances & related key performance metrics, such as days sales outstanding (DSO), AR aging, unbilled or held revenue, and cash. With 24/7 reimbursement monitoring and customized coaching, Prochant Pulse serves as a vital-signs monitor for pharmacy reimbursement processes.

“Prochant Pulse’s integration with WeInfuse reflects our commitment to empowering infusion providers through advanced technology. It is not just about effective revenue cycle management – it is about reshaping the industry standard and revolutionizing how providers optimize their operations,” said Jon Love, Vice President of Pharmacy Services at Prochant.

By leveraging Prochant Pulse, infusion pharmacy providers can benefit from:

• Faster and more successful A/R closures
• Reduced administrative and staffing costs
• Decreased human errors
• Reduced claim denials
• Improved cash flow

Many clients utilizing Prochant services have experienced a DSO under 40 days. Their testimonials highlight the unwavering support from the Prochant team, which has enabled them to streamline their operations and allocate more energy towards delivering exceptional patient care. Jon Love, along with Prochant’s team of infusion pharmacy reimbursement experts, will be attending the National Infusion Center Association (NICA) Annual Conference happening June 23-24 in Miami. Visit Prochant’s booth #209 to see a demo of AI-driven tools and analytics in combination with our expert RCM team to optimize the reimbursement process.

To schedule a demo of Prochant Pulse or to receive a complimentary reimbursement audit, visit prochant.com or email marketing@prochant.com

ABOUT WEINFUSE

WeInfuse is the premier technology and consulting provider for infusion therapy and medication delivery in the U.S. The WeInfuse software platform powers over 700 infusion centers across the country. Backed by decades of experience, WeInfuse consulting services guide clients through the dynamic infusion landscape.

WeInfuse has expanded its software platform to include a complete home infusion and specialty pharmacy workflow. WeInfuse software helps organizations operate efficiently, maximize profitability, decrease burnout, and improve clinical outcomes. Its powerful, intuitive features for infusion workflows and a robust reporting and analytics engine help take the confusion out of infusion. To learn more, email marketing@weinfuse.com or visit http://www.weinfuse.com.

ABOUT PROCHANT

Prochant is the only AI-driven reimbursement service provider in the home-based care industry. We deliver focused revenue cycle management (RCM) solutions to healthcare providers with 7 wholly-owned global delivery centers. Our expertise lies in providing end-to-end RCM for home-based care, infusion, and specialty pharmacies, consistently delivering exceptional results to some of the leading healthcare providers in the country. We harness specialized automation technology and deep industry knowledge to streamline the time-consuming and expensive reimbursement process. As a result, we help healthcare providers accelerate their collections, increase revenue, and reduce operational costs while managing risk. Prochant is HITRUST certified, the gold standard for HIPAA security.

Share article on social media or email: